Align Technology, Inc. $ALGN Stock Acquired by State of Alaska Department of Revenue

Posted by George Bondi on Oct 15th, 2026

State of Alaska Department of Revenue lifted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 821.2% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 167,271 shares of the medical equipment provider’s stock after buying an additional 149,113 shares during the period. State of Alaska Department of Revenue’s holdings in Align Technology were worth $22,362,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. grew its holdings in shares of Align Technology by 77.5% during the first quarter. Blue Trust Inc. now owns 158 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 69 shares during the last quarter. Tobam acquired a new position in shares of Align Technology in the fourth quarter valued at approximately $30,000. Hollencrest Capital Management bought a new position in Align Technology in the 1st quarter valued at approximately $34,000. Osterweis Capital Management Inc. bought a new position in Align Technology in the 2nd quarter valued at approximately $36,000. Finally, Global Retirement Partners LLC bought a new position in Align Technology in the 2nd quarter valued at approximately $38,000. Institutional investors own 88.43% of the company’s stock.

Analysts Set New Price Targets

ALGN has been the topic of a number of analyst reports. BMO Capital Markets began coverage on Align Technology in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $209.00 price target on the stock. Stifel Nicolaus cut their price objective on Align Technology from $210.00 to $175.00 and set a “buy” rating on the stock in a research note on Friday, October 9th. Evercore lowered Align Technology from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research note on Monday, October 5th. Weiss Ratings upgraded Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 9th. Finally, Raymond James Financial reissued a “buy” rating on shares of Align Technology in a research report on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $194.14.

View Our Latest Stock Analysis on Align Technology

Align Technology Stock Performance

Align Technology stock traded up $3.76 during mid-day trading on Thursday, reaching $148.20. The stock had a trading volume of 360,316 shares, compared to its average volume of 1,059,615. The firm has a market capitalization of $10.61 billion, a PE ratio of 25.78, a price-to-earnings-growth ratio of 1.53 and a beta of 1.67. Align Technology, Inc. has a fifty-two week low of $128.65 and a fifty-two week high of $200.43. The stock’s 50-day simple moving average is $154.93 and its 200-day simple moving average is $167.44.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, topping analysts’ consensus estimates of $2.62 by $0.02. Align Technology had a return on equity of 15.86% and a net margin of 9.99%. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the firm earned $2.49 earnings per share. Align Technology’s revenue for the quarter was up 4.3% on a year-over-year basis. On average, research analysts forecast that Align Technology, Inc. will post 9.36 earnings per share for the current fiscal year.

Align Technology Company Profile

(Free Report)

Align Technology, Inc is a medical device and digital technology company that designs, manufactures and markets products used in orthodontics and restorative dentistry. The company is best known for Invisalign clear aligners, which are custom-made orthodontic devices intended to gradually move patients’ teeth under the supervision of dental professionals.

Align also develops the iTero family of intraoral scanners and related digital imaging systems, which help dental professionals create digital impressions and treatment plans.